NeoGenomics's total assets for Q2 2025 were $1.39B, a decrease of -12.96% from the previous quarter. NEO total liabilities were $439.79M for the fiscal quarter, a -38.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.